Engagement in HIV Care Clinical Trial
— LINCOfficial title:
Overcoming Barriers to HIV/AIDS Care and ART Initiation
| Verified date | March 2019 |
| Source | University of Washington |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
The study will evaluate interventions to improve engagement in HIV care following HIV diagnosis through a voluntary counseling and testing program. The specific aims are to (1) determine if a VCT-based intervention of CD4 count testing, alone or in combination with peer counseling, improves linkage to HIV/AIDS care; (2) assess the impact of the intervention on ART initiation. The study will recruit 450 HIV-positive individuals from VCTs and randomize a third to standard counseling and referral, a third to receive CD4 testing at the VCT with results return by phone after 1 weeks, and a third to receive the same CD4 testing combined with peer counseling. These combined investigations will create a comprehensive understanding of obstacles to appropriate HIV/AIDS care and result in new interventions to achieve measurable outcomes in applied settings.
| Status | Completed |
| Enrollment | 315 |
| Est. completion date | December 22, 2017 |
| Est. primary completion date | December 22, 2017 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: - At least 18 years or older and - Testing HIV-positive for the first time at a voluntary counseling and testing (VCT) center. - Willing to receive counseling to encourage linkage to care at a comprehensive care center (CCC). - Willing to have a CD4 count test conducted at the enrollment visit. - Willing to have a telephone follow-up where they may receive additional counseling and/or have their CD4 count results returned to them. - Willing to be contacted over 1 year to determine if they linked to care. Exclusion Criteria: - Previous positive HIV test. - Currently taking antiretroviral medications. - Currently pregnant (females only). - Currently participating in another research study or trial. - Not planning to remain in Nairobi for the next 12 months (not including short trips out of Nairobi). |
| Country | Name | City | State |
|---|---|---|---|
| Kenya | Karen Health Center | Nairobi |
| Lead Sponsor | Collaborator |
|---|---|
| University of Washington |
Kenya,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Number of days from study enrollment until first visit to a comprehensive care center for HIV care. | An interviewer administered questionnaire will be used to determine if each participant visited a comprehensive care center. Is so, the date of the first visit will be recorded. From this, the time from enrollment until first visit to a comprehensive care center will be calculated. | 1 year | |
| Primary | Number of days from study enrollment until initiation of antiretroviral therapy. | An interviewer administered questionnaire will be used to determine if each participant started antiretroviral therapy. Is so, the date of treatment initiation will be recorded. From this, the time from enrollment until treatment initiation will be calculated. | 1 year | |
| Secondary | Interviewer-administered questionnaire to determine the number of visits made to a comprehensive care center for HIV care. | Measurement of the number of visits to a comprehensive care center will be made questionnaire administered in an in-person interview at 12 months after enrollment. The total number of visits will be recorded. | 1 year | |
| Secondary | Measurement of CD4+ T-cell count. | Each participant's CD4 count will be measure at 1 year after enrollment. | 1 year |